Pharmacology and immunology of botulinum toxin serotypes

Journal of Neurology, Supplement

Volumn 248, Issue SUPPL. 1, 2001, Pages

  Aoki, K R ^a  

^a ALLERGAN INC   (United States)

Author keywords

Analgesia; Botox ; Botulinum toxin type A; Botulinum toxin type B; Chemodenervation; Dysport ; Myobloc ; Safety margin

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEUTRALIZING ANTIBODY;

ANALGESIA; ANTINOCICEPTION; ARTICLE; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; LONG TERM CARE; MOTOR DYSFUNCTION; NEUROTRANSMITTER RELEASE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SEROTYPE; XEROSTOMIA;

EID: 0035076007     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00007816     Document Type: Article

References (81)

1. Botulinum toxin therapy: Basic science and therapeutic overview of other applications
2. Clostridial toxins as therapeutic agents: Benefits of nature's most toxic proteins
3. Development of BOTOX® - Its history and pharmacology
4. Botulinum toxin injections for cervical dystonia
5. Therapeutic uses of botulinum toxin
6. Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: A double-blind, controlled study
7. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
8. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
9. Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in humans
10. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans
11. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
12. Botulinum toxin type F for treatment of dystonia: Long-term experience
13. Human response to botulinum toxin injection: Type A compared with type B
14. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A
15. Botulinum toxin: Historical perspective and potential new indications
16. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial
17. Botulinum toxin in the management of the lower limb in cerebral palsy
18. Effect of treatment with botulinum toxin on spasticity
19. Treatment of spasticity with botulinum toxin: A double-blind study
20. Botulinum toxin for achalasia
21. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure
22. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
23. Botulinum A toxin injection in focal hyperhidrosis
24. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm
25. Axotomy-like changes in cat motorneuron electrical properties elicited by botulinum toxin depend on the complete elimination of neuromuscular transmission
26. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals
27. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis
28. Histological assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections
29. Botulinum A toxin effects on rat jaw muscle spindles
30. Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection
31. Botulinum neurotoxin alters the discharge characteristics of abducens motoneurons in the alert cat
32. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: Ultrastructural and synaptic alterations
33. Dose-dependent, central effects of botulinum neurotoxin type A: A pilot study in the alert behaving cat
34. Effects of botulinum neurotoxin type A on the expression of gephyrin in cat abducens motoneurons
35. Dose standardization of botulinum toxin
36. Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes
37. Neuromuscular effects distant from the site of botulinum neurotoxin injection
38. Preclinical update on BOTOX® (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations
39. Double-blind study of botulinum toxin in spasmodic torticollis
40. Ocular involvement in benign botulism B
41. Botulism
42. Structure, activity and immune (T and B cell) recognition of botulinum neurotoxins
43. Response and immunoresistance to botulinum toxin injections
44. Development of resistance to botulinum toxin type A in patients with torticollis
45. Botulinum toxin therapy, immunologic resistance, and problems with available materials
46. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum toxin type A and their cross-reaction with Hc
47. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum
48. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B, and E: Use of hapten-labeled-antibody elution to isolate specific complexes
49. Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
50. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
51. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
52. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis
53. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm
54. Botulinum toxin A improves the rigidity of progressive supranuclear palsy
55. Treatment of tension-type headache with botulinum toxin: A pilot study
56. Botulinum toxin A adjunctive therapy for refractory headaches associated with pericranial muscle tension
57. Tension headache: Botulinum toxin paralysis of temporal muscles
58. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A
59. Botulinum toxin type A injections for myofascial pain syndromes and tension-type headache
60. Treatment of tension-type headache by local injection of botulinum toxin
61. Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial
62. Treatment of whiplash associated neck pain with botulinum toxin type A: Pilot study
63. Treatment of myofascial pain with botulinum A toxin
64. Botulinum toxin in the treatment of myofascial pain syndrome
65. Botulinum toxin type A (BTX-A) for migraine: An open label assessment
66. Botulinum toxin type A as a migraine preventative treatment
67. Botulinum toxin A and chronic low back pain: A randomized, double blind study
68. Botulinum toxin is unsatisfactory therapy for fibromyalgia
69. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes
70. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms
71. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins
72. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles
73. Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody
74. Immunogenicity of neurotoxins of Clostridium botulinum
75. BOTOX (botulinum toxin type A) purified neurotoxin complex prepared from the new bulk toxin retains the same preclinical efficacy as the original but with reduced immunogenicity
76. Use of botulinum toxin in anal fissure
77. One hundred cases of anal fissure treated with botulin toxin